fundvisualizer.com

Goldman Sachs Intl Eq Insghts CGCICX

Performance (before sales charge)

As of 08/31/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 04/30/2023
Stock
0.21%
Non-U.S. Stock
99.84%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
-0.05%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 04/30/2023

Basic materials

5.60%

Consumer cyclical

14.01%

Financial services

16.00%

Real estate

0.99%

Consumer defensive

10.01%

Health care

15.13%

Utilities

3.26%

Communication services

2.46%

Energy

3.80%

Industrials

17.47%

Technology

9.88%

Top 10 holdings

As of 04/30/2023

ASML Holding NV
2.45%
Novo Nordisk A/S Class B
2.07%
Novartis AG Registered Shares
1.94%
Sanofi SA
1.63%
BHP Group Ltd
1.57%
Shell PLC
1.48%
SAP SE
1.48%
Compagnie Financiere Richemont SA Class A
1.43%
British American Tobacco PLC
1.38%
Commonwealth Bank of Australia
1.38%
Fund assets

$1.66 Billion

Share class

C

Morningstar category

Foreign Large Blend

Expense ratio

1.93%

Investment objective

Foreign Stock

Documents